登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：600505 证券简称：西昌电力 公告编号：2025-035 四川西昌电力股份有限公司 关于召开2024年度暨2025年第一季度业绩暨现金分红说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： 会议召开时间：2025年06月05日 （星期四） 09:30-10:30 会议召开地点：上海证券交易所上证路演中心（网址：https://roadshow.sseinfo.com/） 会议召开方式：上证路演中心视频直播和网络互动 投资者可于2025年05月28日 （星期三） 至06月04日 （星期三）16:00前登录上证路演中心网站首页点 击"提问预征集"栏目或通过公司邮箱xcdlgs@126.com进行提问。公司将在说明会上对投资者普遍关注的 问题进行回答。 四川西昌电力股份有限公司（以下简称"公司"）已于2025年4月18日发布公司《2024年年度报告》 《2024年度利润分配预案的公告》，2025年4月30日发布《2025年第一季度报告》，为便于 ...

会，就投资者关心的问题进行交流。 四川西昌电力股份有限公司 关于召开 2024 年度暨 2025 年第一季度业绩暨现金分 红说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 会议召开时间：2025 年 06 月 05 日 （星期四） 09:30-10:30 会议召开地点：上海证券交易所上证路演中心（网址： https://roadshow.sseinfo.com/） 会议召开方式：上证路演中心视频直播和网络互动 投资者可于 2025 年 05 月 28 日 （星期三） 至 06 月 04 日 （星 期三）16:00 前登录上证路演中心网站首页点击"提问预征集"栏目 或通过公司邮箱 xcdlgs@126.com 进行提问。公司将在说明会上对投 资者普遍关注的问题进行回答。 四川西昌电力股份有限公司（以下简称"公司"）已于 2025 年 4 月 18 日发布公司《2024 年年度报告》《2024 年度利润分配预案的 公告》，2025 年 4 月 30 日发布《2025 年第一季度报告》，为便于广 大投资 ...

西昌电力(600505)今日跌停，全天换手率15.61%，成交额9.21亿元，振幅7.84%。龙虎榜数据显示，营 业部席位合计净卖出9392.95万元。 4月30日公司发布的一季报数据显示，一季度公司共实现营业收入3.87亿元，同比增长7.25%，实现净利 润135.53万元，同比增长111.08%。（数据宝） 西昌电力5月23日交易公开信息 | 买/ | 会员营业部名称 | 买入金额（万 | 卖出金额（万 | | --- | --- | --- | --- | | 卖 | | 元） | 元） | | 买一 | 东方财富证券股份有限公司拉萨金融城南环路证券营业部 | 1143.63 | | | 买二 | 东方财富证券股份有限公司拉萨团结路第一证券营业部 | 885.64 | | | 买三 | 东方财富证券股份有限公司拉萨东环路第一证券营业部 | 847.84 | | | 买四 | 东方财富证券股份有限公司拉萨东环路第二证券营业部 | 812.38 | | | 买五 | 国信证券股份有限公司浙江互联网分公司 | 796.32 | | | 卖一 | 国泰海通证券股份有限公司总部 | | 5355.53 | | 卖 ...

Group 1 - Huiyu Pharmaceutical's subsidiary received drug registration certificate for Carboxymethyl Sodium Injection, which is used for treating bleeding diseases in various medical fields [1] - Baihe Co., Ltd. announced a plan for a director to reduce holdings by up to 424,000 shares, representing 0.6625% of the total share capital [1] - Kingood Co., Ltd. received a notification from a global leading automaker for a wheel project, expected to start mass production in 2026 with a lifecycle of 10 years [1][2] Group 2 - Wanhua Chemical plans to repurchase shares worth between 300 million and 500 million yuan, with a maximum repurchase price of 99.36 yuan per share [2] - Warner Pharmaceutical's subsidiary received approval for Acetylcysteine raw material drug, primarily used for treating respiratory diseases [3] - ST Mingcheng plans to publicly transfer 45% equity of its subsidiary, aiming to optimize asset structure [4] Group 3 - Qixia Construction announced a plan to reduce up to 31.5 million shares, accounting for 3% of total share capital [5][6] - Zhejiang Rongtai intends to invest 20 million yuan to establish a wholly-owned subsidiary focused on intelligent robotics [7] - Yuandong Biological received drug registration for Chloral Hydrate Enema, used for sedation and seizure control in children [9] Group 4 - Jiemai Technology's subsidiary signed a strategic cooperation agreement with a solid-state battery company to produce high-safety composite conductive materials [10] - Xianju Pharmaceutical received drug registration for Progesterone Soft Capsules, used for treating functional disorders due to luteal deficiency [11] - Lanhua Kecai's subsidiary reported a temporary production halt, with the resumption date yet to be determined [13] Group 5 - Sinopharm Modern's subsidiary received drug registration for Tocilizumab Tablets, used for treating rheumatoid arthritis and other conditions [15] - Shanghai Bank announced the resignation of its vice president due to organizational adjustments [17] - Shanghai Pharmaceutical's Ephedrine Injection passed the consistency evaluation for generic drugs [19] Group 6 - Rundu Co., Ltd. received drug registration for Amlodipine and Olmesartan Tablets, aimed at treating hypertension [21] - Zhong'an Technology announced that 61 million shares held by its controlling shareholder will be auctioned [23] - Shanghai Washba plans to purchase patent assets and establish two subsidiaries focused on hydrogen energy and solid-state battery technologies [25] Group 7 - Nuo Cheng Jianhua's new drug Tafasitamab received approval for treating relapsed/refractory diffuse large B-cell lymphoma [26] - Benli Technology plans to use up to 200 million yuan of idle funds for cash management and financial investments [28] - Taiji Co., Ltd. intends to use 60 million yuan of idle funds to purchase financial products [29] Group 8 - Haishi Co. announced that its innovative drug Anreke Fen Injection received drug registration for treating postoperative pain [32] - Yulong Co. will have its stock delisted on May 27, 2025, following a decision by the Shanghai Stock Exchange [36] - Weifu High-Tech plans to establish a joint venture with Shanghai Baolong Automotive Technology [38] Group 9 - Xichang Electric Power expects a net profit reduction of approximately 5.4 million yuan due to adjustments in the time-of-use electricity pricing mechanism [39] - Alter signed a contract worth 6.8 billion yen for the development and procurement of large truck EV kits [41] - Zhonglian Heavy Industry plans to acquire controlling stakes in its financing leasing subsidiary through public bidding [42] Group 10 - Sanyou Medical's executive plans to reduce holdings by up to 1.44% of the company's shares [43] - Hangyang Co. plans to establish a subsidiary for large modular cryogenic equipment manufacturing with an estimated investment of 557 million yuan [44] - FAW Fuwi received a notification for a dashboard project from a well-known new energy brand, with total sales expected to reach 1.06 billion yuan [45]

Group 1 - Zhaoyi Innovation plans to issue H-shares and list on the Hong Kong Stock Exchange, considering the interests of existing shareholders and market conditions [3] - ST Zhongdi has decided to abandon the commercial opportunity for the Jiageng Ke Yi City land project, with the controlling shareholder planning to develop the project instead [4] - Xichang Electric Power expects a reduction of approximately 5.4 million yuan in net profit for 2025 due to adjustments in the time-of-use electricity pricing mechanism [5] Group 2 - Sanfu New Materials intends to invest 620 million yuan in a project for high-safety dry electrode battery key materials and high-frequency electronic information composite materials [6] - Weifu High-Tech's subsidiary plans to establish a joint venture with Baolong Technology to expand the active suspension motor hydraulic pump business [7] - Yulong Co., Ltd. will have its stock delisted on May 27, 2025, following a decision by the Shanghai Stock Exchange [8] Group 3 - Chen'an Technology's shareholder is transferring 6.27% of the company's shares to Hefei Guotou, aiming to introduce strategic investors [9] - Huamao Technology is planning to acquire a 100% stake in Fuchuang Youyue, with stock trading suspended for up to 10 trading days [11] - Baolong Technology's subsidiary will collaborate with Weifu High-Tech's subsidiary to develop core components for the active suspension system [12] Group 4 - Zhongnong Lihua intends to acquire at least 50% of Taizhou Agricultural Supplies, enhancing its product and service range [13] - Weiling Co., Ltd.'s subsidiary has successfully acquired 74.3% of Jiayu Mining for 220 million yuan, focusing on expanding into the non-ferrous metal resource sector [14][15] - Hengshi Technology's subsidiary has been approved for public transfer of shares on the New Third Board [16] Group 5 - Xiang Teng New Materials plans to acquire an additional 12.5% stake in its subsidiary Shanghai Shangda for 25.3 million yuan [17] - ST Texin has extended its employee stock ownership plan by 12 months, reflecting confidence in the company's long-term development [18] - Baili Electric has issued a risk warning regarding its stock price increase, indicating no significant changes in fundamentals [19] Group 6 - Hu Silicon Industry plans to acquire minority stakes in three semiconductor companies for approximately 7.04 billion yuan [20][21] - Demais plans to change its controlling shareholder, leading to a temporary suspension of stock trading [22] - FAW Fuwei has received a notice from a well-known new energy brand for a project expected to generate 1.06 billion yuan in total sales over its lifecycle [23] Group 7 - Hangyang Co. plans to establish a subsidiary for a large modular cryogenic equipment manufacturing project with an estimated investment of 557 million yuan [24] - Jiewate intends to acquire 40.89% of Tianyi Hexin for 319 million yuan, enhancing its product line in the signal chain category [25] - Dingxin Communications has elected a new chairman following the resignation of the previous chairman [26][27] Group 8 - Aofei Entertainment plans to invest 10 million yuan in a partnership to indirectly invest in AI robotics company Xuan Yuan Technology [28] - Huaxi Energy's controlling shareholder has been detained, but the company states that operations remain normal [29] - Yihe Jiaye will change its stock name to "Ruimaite" starting May 21 [30] Group 9 - Zhongjin Environment will change its name to "Southern Pump Industry" effective May 21 [31] - Hong Sifang's subsidiary plans to invest approximately 1.49 billion yuan in a new chemical materials and fertilizers industrial park [32] - Buchang Pharmaceutical's subsidiary has signed a research agreement for MF59 adjuvant with a pharmaceutical company [33] Group 10 - Hongjing Technology has signed a service contract worth 597 million yuan for a smart computing project [34] - Zhuojin Co. has won a bid for a soil remediation project worth 67.68 million yuan [35] - Xinjiang Jiaojian has been awarded a contract for a highway project valued at 451 million yuan [36] Group 11 - China National Materials Energy's subsidiary has signed a contract for an EPC project in Uzbekistan worth approximately 1.252 billion yuan [37] - Ruixin Microelectronics' shareholder plans to reduce its stake by up to 2% [38] - Shanghai Yizhong's shareholder also plans to reduce its stake by up to 2% [39] Group 12 - Sanyou Medical's controlling shareholder plans to reduce its stake by up to 1.44% [40] - Hangdian Co.'s controlling shareholder plans to reduce its stake by up to 1.93% [41] - Shangwei New Materials' shareholder plans to reduce its stake by up to 3% [42] Group 13 - Mingchen Health plans to repurchase shares worth between 30 million and 50 million yuan [43] - Jiuhua Tourism plans to raise up to 500 million yuan through a private placement for various projects [44] - Yuegui Co. plans to raise up to 900 million yuan for several projects [46]

Group 1 - Zhaoyi Innovation plans to issue H-shares and list on the Hong Kong Stock Exchange, considering the interests of existing shareholders and market conditions [3] - ST Zhongdi has decided to abandon the commercial opportunity for the Jiageng Science and Art City land project, which has an area of 108,600 square meters and a starting price of 2.067 billion yuan [4] - Xichang Electric Power expects a reduction of approximately 5.4 million yuan in net profit for 2025 due to adjustments in the time-of-use electricity pricing mechanism [5] Group 2 - Sanfu New Technology plans to invest 620 million yuan in a project for high-safety dry electrode battery key materials and high-frequency electronic information composite materials, with production expected to start in June 2025 [6] - Weifu High-Tech's subsidiary will establish a joint venture with Baolong Technology to expand the business of fully active suspension motor hydraulic pumps, with a registered capital of 400 million yuan [7] - Yulong Co., Ltd. will have its stock delisted on May 27, 2025, following a decision by the Shanghai Stock Exchange [8] Group 3 - Chensan Technology's shareholder Shanghai Ruiwei will transfer 14.58 million shares, representing 6.27% of the company, to Hefei Guotou, with the transfer price set at 17.7 yuan per share [10] - Huamao Technology is planning to acquire a 100% stake in Fuchuang Youyue, currently holding 42.16% of the company, with stock trading suspended for up to 10 days [11] - Baolong Technology's subsidiary will partner with Weifu High-Tech's subsidiary to develop and mass-produce core components for fully active suspension systems [12] Group 4 - Buchang Pharmaceutical's subsidiary has signed a commissioned research agreement with Fubicheng Pharmaceutical for the MF59 emulsion adjuvant [14] - Hongjing Technology has signed a service contract worth 597 million yuan for a smart computing project, with a duration of five years [15] - Zhuojin Co., Ltd. has won a bid for a soil remediation project worth 67.68 million yuan, with an expected share of approximately 59.9 million yuan [16] - Xinjiang Jiaojian has been awarded a contract for the G3013 line Ucha to Kangsou highway project, with a bid amount of 451 million yuan [17] Group 5 - Mingchen Health plans to repurchase shares worth between 30 million and 50 million yuan for employee stock ownership plans, with a maximum repurchase price of 23 yuan per share [19]

关于分时电价机制调整的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 四川省发展和改革委员会发布了《关于进一步调整我省分时电价机制的通 知》（川发改价格〔2025〕185 号），自 2025 年 5 月 1 日起执行。 证券代码：600505 证券简称：西昌电力 公告编号：2025-034 四川西昌电力股份有限公司 现将本次调整的主要内容及对公司的影响公告如下： 四川西昌电力股份有限公司董事会 2025 年 5 月 21 日 报备文件 四川省发展和改革委员会关于进一步调整我省分时电价机制的通知》（川发 改价格〔2025〕185 号） 3.电价执行范围调整。用电负荷（容量）在 50 千瓦（千伏安）以下的工商 业用户可自愿选择执行分时电价。 二、本次分时电价机制调整对公司的影响 本次分时电价机制调整对公司经营业绩会造成一定影响。全年增加低谷时长 180 小时、减少平段时长 180 小时，并将 180 小时高峰时段由用电价格相对较高 的春秋季调整到价格较低的夏季。工商业用户结合分时电价机制调整合理安排生 产计划，公司大工业用户 ...

Group 1 - The Central Meteorological Administration issued a yellow high-temperature warning, predicting temperatures of 35-36°C in various regions including Inner Mongolia, Gansu, Ningxia, and parts of Shaanxi, Shanxi, Hebei, and others, with some areas reaching 37-39°C and localized spots exceeding 40°C [1] - The Shandong Provincial Meteorological Administration also issued an orange high-temperature warning, forecasting temperatures above 35°C in several regions, with specific areas expected to reach 40-42°C [1] - In Henan, temperatures surged to 40°C and above, with Linzhou hitting a record 43.2°C, and surface temperatures exceeding 70°C in some locations [2] Group 2 - The power sector saw significant stock movements, with companies like Leshan Electric hitting the daily limit, and others such as Hunan Development and Xichang Electric also experiencing gains [2] - According to Minsheng Securities, the decline in coal prices and steady growth in thermal power performance in Q1 2023 suggest that the upcoming peak electricity usage season in Q2 and Q3 could lead to continued performance improvements for companies, especially those investing in wind power and cogeneration [2] - Huayuan Securities noted that while thermal power operators are expected to see improved performance in Q1 2025, there is a growing disparity in profitability, with northern units performing better than those in the Yangtze River Delta region [3]

四川元航律师事务所 四川元航律师事务所 四川西昌电力股份有限公司 2024 年年度股东会法律意见书 致:四川西昌电力股份有限公司 四川元航律师事务所(以下简称:本所)受四川西昌电力股份有 限公司(以下简称:公司)的委托,指派马胤鹏律师、吴星宇律师列 席了公司于 2025年 05 月 15 日召开的 2024 年年度股东会( 以下简称: 本次股东会),并依据《中华人民共和国公司法》(以下简称:《公司 法》)、《中华人民共和国证券法》(以下简称:《证券法》、中国证券 监督管理委员会《上市公司股东会规则》(以下简称:《股东会规则》) 等中国现行法律、法规和规范性文件以及《四川西昌电力股份有限公 司章程》(以下简称:《公司章程》)的有关规定,就本次股东会的召 集和召开程序、出席会议人员资格、召集人资格、表决程序、表决结 果等相关法律问题出具法律意见书。 为出具本法律意见书,本所律师审查了公司提供的有关本次服东 会的文件,听取了公司就有关事实的陈述和说明,列席了本次股东会。 公司承诺其所提供的文件和所作的陈述和说明是完整、真实和有效的, 无任何隐瞒、疏漏之处。 在本法律意见书中,本所仅根据本法律意见书出具前发生的事实 ...

证券代码：600505 证券简称：西昌电力 公告编号：2025-033 四川西昌电力股份有限公司 2024年年度股东会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 本次会议是否有否决议案：无 一、 会议召开和出席情况 | 1、出席会议的股东和代理人人数 | 644 | | --- | --- | | 2、出席会议的股东所持有表决权的股份总数（股） | 203,609,470 | | 3、出席会议的股东所持有表决权股份数占公司有表决权股 | | | 份总数的比例（%） | 55.8495 | (四) 表决方式是否符合《公司法》及《公司章程》的规定，大会主持情况等。 是 (一) 股东会召开的时间：2025 年 5 月 15 日 (二) 股东会召开的地点：四川省西昌市胜利路 66 号公司办公大楼 6 楼会议室 (三) 出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况： (五) 公司董事、监事和董事会秘书的出席情况 3、 董事会秘书晏科出席会议；部分高级管理人员列席会议。 1、 议案名称：202 ...